Stock Information
Spyre Therapeutics Inc (SYRE)
Ticker Symbol: SYRE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,337.24 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.5525
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -31.14%
Latest News
-
BTIG Reiterates Buy on Spyre Therapeutics, Maintains $70 Price Target
Tue, Mar 31, 2026 6:31 AM
Key Financials
Financial data not available